Mirum Pharmaceuticals, Inc.

NasdaqGM:MIRM Stock Report

Market Cap: US$2.0b

Mirum Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGM:MIRM Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
18 Sep 24BuyUS$4,301Frazier Life Sciences Management, LPCompany115US$37.40
06 Sep 24BuyUS$9,563Frazier Life Sciences Management, LPCompany230US$41.58
27 Mar 24BuyUS$49,600Eric BjerkholtIndividual2,000US$24.80
25 Mar 24SellUS$111,017Peter RadovichIndividual4,303US$25.80
18 Mar 24BuyUS$51,600Eric BjerkholtIndividual2,000US$25.80
02 Feb 24SellUS$157,491Christopher PeetzIndividual6,013US$26.19
02 Feb 24SellUS$31,797Pamela VigIndividual1,214US$26.19
02 Feb 24SellUS$46,883Peter RadovichIndividual1,790US$26.19
02 Feb 24SellUS$22,184Lara LongpreIndividual847US$26.19
08 Jan 24SellUS$146,033Christopher PeetzIndividual5,209US$28.03
08 Jan 24SellUS$39,472Pamela VigIndividual1,408US$28.03
08 Jan 24SellUS$39,473Peter RadovichIndividual1,408US$28.03
08 Jan 24SellUS$28,568Lara LongpreIndividual1,019US$28.04

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of MIRM?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders832,2461.5%
Hedge Funds4,370,0247.86%
VC/PE Firms6,495,50711.7%
Institutions43,894,66279%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 2.3%.

Top Shareholders

Top 25 shareholders own 92.41% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
13.6%
Frazier Life Sciences Management, LP
6,495,507US$270.3m0%9.88%
10.5%
Janus Henderson Group plc
4,988,747US$207.6m80.3%0.08%
9.16%
BVF Partners L.P.
4,370,024US$181.8m0%4.36%
7.58%
Eventide Asset Management, LLC
3,614,820US$150.4m9.53%2.36%
7.06%
BlackRock, Inc.
3,368,157US$140.1m4.02%no data
5.13%
The Vanguard Group, Inc.
2,446,733US$101.8m10.6%no data
3.71%
Rock Springs Capital Management LP
1,772,038US$73.7m-4.55%2.12%
3.32%
Citadel Advisors LLC
1,585,624US$66.0m13.9%0.06%
3.14%
Novo Holdings A/S
1,500,000US$62.4m0%0.04%
3.14%
State Street Global Advisors, Inc.
1,496,217US$62.3m-47%no data
2.7%
Tang Capital Management, LLC
1,287,107US$53.6m8.42%4.34%
2.59%
Cadian Capital Management, LP
1,235,121US$51.4m-46.1%2.01%
2.51%
T. Rowe Price Group, Inc.
1,199,220US$49.9m-24.9%no data
1.97%
Franklin Resources, Inc.
938,881US$39.1m0%0.01%
1.9%
Geode Capital Management, LLC
907,180US$37.7m30.1%no data
1.83%
Pictet Asset Management Limited
875,113US$36.4m-8.45%0.03%
1.66%
Medical Strategy GmbH, Asset Management Arm
794,125US$33.0m-11.6%1.86%
1.55%
Polar Capital Holdings Plc
741,049US$30.8m18.6%0.11%
1.53%
Avidity Partners Management, L.P.
731,104US$30.4m-36%1.17%
1.52%
Goldman Sachs Group, Investment Banking and Securities Investments
726,645US$30.2m9.01%0.01%
1.47%
ClearBridge Investments, LLC
699,933US$29.1m166%0.02%
1.36%
First Turn Management, LLC
647,611US$26.9m-7.93%4.1%
1.29%
Norges Bank Investment Management
614,905US$25.6m-15.5%no data
1.11%
Morgan Stanley, Investment Banking and Brokerage Investments
529,030US$22.0m53.7%no data
1.1%
Boone Capital Management LLC
523,679US$21.8m15.9%5.06%